University of Colorado Hemophilia and Thrombosis Center — Aurora, Colorado

University of Colorado Hemophilia and Thrombosis Center is a clinical research site located in Aurora, Colorado, United States 80045.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Colorado Hemophilia and Thrombosis Center has participated in 6 clinical trials with 3 currently active.

Therapeutic areas: Hemophilia B, Hemophilia A, Hemophilia A, Congenital.

Sponsors: Regeneron Pharmaceuticals, Bayer, Catalyst Biosciences.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Colorado Hemophilia and Thrombosis Center?

University of Colorado Hemophilia and Thrombosis Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Colorado Hemophilia and Thrombosis Center conducted?

University of Colorado Hemophilia and Thrombosis Center has 6 clinical trials on record, with 3 currently active. Their work covers Hemophilia B, Hemophilia A, Hemophilia A, Congenital.

Is University of Colorado Hemophilia and Thrombosis Center accredited by Crixeo Health?

Yes — University of Colorado Hemophilia and Thrombosis Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Colorado Hemophilia and Thrombosis Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.